Sadness at sudden death of Addenbrooke’s consultant rheumatologist Dr Deepak Jadon

Tributes have been paid to Addenbrooke's consultant Dr Deepak Jadon following his sudden death.

Described as a “hugely talented medic” who was “devoted to his patients”, Dr Jadon was a consultant rheumatologist, director of the Rheumatology Research Unit and lead for psoriatic arthritis (PsA) at the Cambridge hospital, where he had worked since 2016.

He was also a bye-fellow of Emmanuel College, having joined in October 2020, and was one of its directors of studies for clinical medicine.

In a statement, Emmanuel said: “The college are greatly saddened by the passing of Dr Jadon. He was a valued member of the Emmanuel community, a hugely talented medic, and a dedicated and supportive teacher and mentor to his students.”

Dr Jadon grew up in Cardiff and graduated from the University of Wales College of Medicine there in 2003. He completed clinical training in rheumatology and general internal medicine in Bath and Bristol between 2007 to 2015, and completed his PhD thesis on the biomarkers of PsA phenotypes at the Royal National Hospital for Rheumatic Diseases in Bath in 2015.

He had expertise in the investigation and management of PsA, ankylosing spondylitis (AS), spondyloarthritis (SpA) and rheumatoid arthritis and was qualified in the use of musculoskeletal ultrasound.

His research explored genetic and serum biomarkers of PsA, AS, and SpA, particularly those predicting prognosis and developing psoriatic spondyloarthropathy or arthritis mutilans.

He researched the clinical and radiographic differences between PsA and AS, and explored juvenile versus adult-onset AS.

At the Rheumatology Research Unit, he led phase IIa to phase IV clinical studies of novel therapeutic agents for PsA, AS, SpA and RA.

He was a trustee of the charity CARE (Cambridge Arthritis Research Endeavour).

Prof Hill Gaston, chair of trustees, said: “Some of you will have known Dr Jadon as one of his patients, and may also have participated in clinical trials which he undertook. He was devoted to his patients, provided outstanding clinical care and was hugely talented.

“Dr Jadon also worked tirelessly on behalf of CARE and its research activities. His expertise, energy and enthusiasm will be very greatly missed by everyone who worked with him.

“I am sure you will join me in keeping Dr Jadon’s family, and all those with whom he worked, in our thoughts and prayers at this sad time.”

Dr Jadon died on November 17.